{"authors":[{"name":"wx3959 wx3959","email":"wx3959@gmail.com"},{"name":"Yueyan Li","email":"yueyan.li@outlook.com"},{"name":"zipei.yang zipei.yang","email":"zipei.yang@stud.ki.se"}],"updated":"2025-11-14T19:18:34+01:00","name":"GLOBE Score Final","description":"","id":"globe_score_final","version":"3.1.2","format":"CambioForm.v1.1","templates":[{"alias":"T0","id":"GLOBE_Score_Final_Template","version":"16.0.0","type":"openEhrOpt14Template"}],"locale":"en","actions":[{"condition":"T0_age && T0_platelet_count && T0_total_bilirubin && T0_uln_of_bilirubin && T0_alp && T0_upper_limit_of_normal_alp && T0_albumin && T0_lln_of_albumin","assignments":["indicator.hidden = true","Result.hidden = false"],"otherwise":["indicator.hidden = false","Result.hidden = true"],"name":"Display results & Hide indicator"},{"condition":"diminish == 'at0018'","assignments":["indicator_1.hidden = false","indicator_2.hidden = true"],"otherwise":["indicator_1.hidden = true","indicator_2.hidden = false"],"name":"Display a judgment on the diminishment"}],"guidelines":[{"condition":"T0_age && T0_platelet_count && T0_total_bilirubin && T0_alp && T0_upper_limit_of_normal_alp && T0_albumin && T0_lln_of_albumin && T0_uln_of_bilirubin","execution":[{"id":"GLOBE_Score_Final","version":"0.0.1"}]}],"elements":[{"type":"form","children":[{"type":"container","children":[{"type":"row","children":[{"type":"column","spanlarge":12,"spanmedium":8,"spansmall":4,"children":[{"type":"section","children":[{"type":"text","textalign":"center","id":"Title"},{"type":"text","textalign":"center","id":"Description"},{"type":"divider","size":"m"}]},{"type":"card","children":[{"type":"accordion","id":"accordion1","children":[{"type":"accordion-item","id":"Instruction","hidden":false,"iconPlacement":"left","open":false,"readonly":false,"children":[{"type":"card","children":[{"type":"text","textalign":"start","id":"text_4"}]}]}]},{"type":"text","textalign":"start","id":"text_1"},{"type":"row","children":[{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_age","unitoptions":[{"unit":"a","precision":0,"min":18,"max":200}],"required":true,"justifyLabel":"start","alignLabel":"center"}]},{"type":"column","spanlarge":1,"spanmedium":2,"spansmall":2},{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_platelet_count","unitoptions":[{"unit":"10*9/l","min":1,"minexclusive":false,"maxexclusive":true,"precision":0}],"required":true,"justifyLabel":"start","alignLabel":"center"}]}]},{"type":"row","children":[{"type":"column","spanlarge":35,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_total_bilirubin","unitoptions":[{"unit":"mg/dl","min":0,"minexclusive":false,"maxexclusive":true},{"unit":"umol/l","precision":2}],"required":true,"justifyLabel":"start","alignLabel":"center"}]},{"type":"column","spanlarge":1,"spanmedium":2,"spansmall":2},{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_uln_of_bilirubin","unitoptions":[{"unit":"mg/dl","min":0,"minexclusive":false,"maxexclusive":true},{"unit":"umol/l"}],"required":true,"justifyLabel":"start","alignLabel":"center"}]}]},{"type":"row","children":[{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_alp","unitoptions":[{"unit":"U/l","min":0,"minexclusive":false,"maxexclusive":true}],"justifyLabel":"start","alignLabel":"center","required":true}]},{"type":"column","spanlarge":1,"spanmedium":2,"spansmall":2},{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_upper_limit_of_normal_alp","unitoptions":[{"unit":"U/l"}],"required":true,"justifyLabel":"start","alignLabel":"center"}]}]},{"type":"row","children":[{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_albumin","unitoptions":[{"unit":"gm/l"},{"unit":"gm/dl"}],"required":true,"justifyLabel":"start","alignLabel":"center"}]},{"type":"column","spanlarge":1,"spanmedium":2,"spansmall":2},{"type":"column","spanlarge":5,"spanmedium":2,"spansmall":2,"children":[{"type":"input-quantity","name":"T0_lln_of_albumin","unitoptions":[{"unit":"gm/dl"},{"unit":"gm/l"}],"required":true,"justifyLabel":"start","alignLabel":"center"}]}]}]},{"type":"indicator","id":"indicator","variant":"warning","iconplacement":"left"},{"type":"card","id":"Result","readonly":true,"children":[{"type":"text","textalign":"start","id":"text_result"},{"type":"display","id":"T0_globe_score","time":false,"precision":3,"inlineLabel":true},{"type":"display","id":"T0_probability_of_survival_5","precision":2,"inlineLabel":true,"trailingZeroes":false,"readonly":false},{"type":"display","id":"T0_probability_of_survival_10","inlineLabel":true,"precision":2,"justifyLabel":"start"},{"type":"input-select","name":"T0_if_survival_significantly","readonly":true,"display":"buttons","displayValue":false,"inlineLabel":false,"justifyLabel":"start","hidden":true,"id":"diminish"},{"type":"indicator","id":"indicator_1","variant":"error","iconplacement":"left","headless":false,"readonly":false},{"type":"indicator","id":"indicator_2","variant":"success","headless":false,"iconplacement":"left","hidden":false},{"type":"accordion","children":[{"type":"accordion-item","id":"accordion_item_1","children":[{"type":"card","children":[{"type":"text","textalign":"start","id":"text_5"},{"type":"divider","size":"m"},{"type":"text","textalign":"start","id":"text"}]}]}]}]}]}]}]}]}],"locales":{"en":{"[name='T0_age']":{"label":"Age","information":"Years at initiation of UDCA therapy, over 18 years old."},"[name='T0_platelet_count']":{"label":"Platelet count","information":"After one year of UDCA therapy."},"[name='T0_total_bilirubin']":{"label":"Total Serum Bilirubin","information":"After one year of UDCA therapy."},"[name='T0_uln_of_bilirubin']":{"label":"Upper limit of normal Total Serum Bilirubin according to your lab","information":"After one year of UDCA therapy."},"[name='T0_alp']":{"label":"ALP","information":"After one year of UDCA therapy."},"[name='T0_upper_limit_of_normal_alp']":{"label":"Upper limit of normal ALP according to your lab","information":"After one year of UDCA therapy."},"[name='T0_albumin']":{"label":"Serum Albumin","information":"After one year of UDCA therapy."},"[name='T0_lln_of_albumin']":{"label":"Lower limit of normal Serum Albumin according to your lab","information":"After one year of UDCA therapy."},"#T0_globe_score":{"label":"GLOBE Score","unit":"1"},"#T0_probability_of_survival_5":{"label":"Probability of transplant-free survival at 5-year (%)","unit":"1"},"#T0_probability_of_survival_10":{"label":"Probability of transplant-free survival at 10-year (%)","unit":"1"},"#text_1":{"text":"## Please enter required patient's data below:"},"#indicator":{"heading":"Please fill in all required fields."},"#text_result":{"text":"## Results:"},"#accordion_item_1":{"label":"Interpretation of Results"},"#text_4":{"text":"This tool computes the GLOBE score, a globally validated model to predict long-term outcomes for PBC patients.\n\n\n\n- **Purpose: **To predict 5-year and 10-year transplant-free survival.\n- **Applicable Population: **Adult patients (≥18y) with PBC.\n- **Timing: **Strictly to be used 1 year after starting UDCA therapy.\n\n\n\n**NOTE: **Results **DO NOT** replace clinical judgment. **DO NOT** use for:\n\n- Diagnosis or baseline assessment\n- Non-UDCA treated patients"},"#text_5":{"text":"The primary value of the GLOBE score is to compare the patient's result against a validated, age-specific threshold.\n\nThese thresholds represent the cutoff point where a patient's long-term prognosis is considered statistically&nbsp;**worse than**&nbsp;an age- and sex-matched general population.\n\n**GLOBE Score Thresholds by Age:**\n\n\\| Age Group \\| Risk Threshold \\|\n\n\\| &lt; 45 years \\|&nbsp;**\\-0.52**&nbsp;\\|\n\n\\| 45–52 years \\|&nbsp;**0\\.01**&nbsp;\\|\n\n\\| 52–58 years \\|&nbsp;**0\\.60**&nbsp;\\|\n\n\\| 58–66 years \\|&nbsp;**1\\.01**&nbsp;\\|\n\n\\| ≥ 66 years \\|&nbsp;**1\\.69**&nbsp;\\|"},"#Title":{"text":"# **GLOBE score**"},"#Description":{"text":"For patients with Primary Biliary Cholangitis (PBC)\n\nafter one-year Ursodeoxycholic Acid (UDCA) treatment"},"#Instruction":{"label":"Instruction"},"#indicator_1":{"heading":"The transplant-free survival is diminished when comparing with an age- and sex-matched  population."},"#indicator_2":{"heading":"The transplant-free survival is NOT diminished when comparing with an age- and sex-matched  population."},"#diminish":{"label":"Is the transplant-free survival diminished when comparing with an age- and sex-matched  population?","options":[{"text":"Yes","value":"at0018","magnitude":0},{"text":"No","value":"at0019","magnitude":2}]},"#text":{"text":"**IF: The score is AT or BELOW the age threshold**\n\n\n\n- Interpretation: ***Prognosis Not Significantly Different.*** The patient's long-term prognosis is statistically similar to the matched general population.\n- Action: Continue UDCA therapy and routine monitoring.\n\n\n\n**IF: The score is ABOVE the age threshold**\n\n\n\n- Interpretation: ***Prognosis Significantly Worse. ***The patient's long-term prognosis is statistically worse than the matched general population.\n- Action: This patient has an inadequate response to UDCA and is at high risk of disease progression. Strongly consider initiating second-line therapy or referral to a specialist center."}},"zh":{"[name='T0_age']":{"label":"年龄"},"[name='T0_platelet_count']":{"label":"血小板计数"},"[name='T0_total_bilirubin']":{"label":"血清总胆红素"},"[name='T0_uln_of_bilirubin']":{"label":" 血清总胆红素正常值上限"},"[name='T0_alp']":{"label":"碱性磷酸酶"},"[name='T0_upper_limit_of_normal_alp']":{"label":"碱性磷酸酶正常值上限"},"[name='T0_albumin']":{"label":"血清白蛋白"},"[name='T0_lln_of_albumin']":{"label":"血清白蛋白正常值下限"},"#diminish":{"label":"If survival significantly deviated from matched healthy individuals","options":[{"text":"Yes","value":"at0018","magnitude":0},{"text":"No","value":"at0019","magnitude":2}]},"#Instruction":{"label":"用法说明"},"#text_4":{"text":"该工具计算GLOBE评分，这是一个全球验证的模型，用于预测PBC患者的长期预后。\n\n\n\n- 目的：预测5年和10年的无移植生存率。\n- 适用人群：成人PBC患者（≥18岁）。\n- 使用时机：严格要求在开始UDCA治疗后1年使用。\n\n\n\n**请注意：计算结果不能替代临床判断。请勿用于：**\n\n- **诊断或基线评估**\n- **非UDCA治疗的患者**"},"#text_1":{"text":"## 请在下方输入患者数据："},"#indicator":{"heading":"请填写所有必填项"},"#text_result":{"text":"## 结果"},"#T0_globe_score":{"label":"GLOBE评分"},"#T0_probability_of_survival_5":{"label":"5年无移植生存率(%)"},"#T0_probability_of_survival_10":{"label":"10年无移植生存率(%)"},"#indicator_1":{"heading":"与年龄和性别匹配的人群相比，无移植生存率降低。"},"#indicator_2":{"heading":"与年龄和性别匹配的人群相比，无移植生存率没有降低。"},"#Title":{"text":"# GLOBE评分"},"#Description":{"text":"用于接受一年期熊去氧胆酸（UDCA）治疗的原发性胆汁性胆管炎（PBC）患者"},"#accordion_item_1":{"label":"结果解释"},"#text_5":{"text":"GLOBE评分的核心价值在于将患者的得分与一个经过验证的、特定于年龄的阈值进行比较。\n\n这些阈值是区分点的界限，用于判断患者的长期预后是否在统计上**差于**同年龄和性别匹配的健康人群。\n\nGLOBE评分的年龄阈值：\n\n\\| 年龄组 \\| 风险阈值 \\|\n\n\\| &lt; 45 岁 \\| -0.52 \\|\n\n\\| 45–52 岁 \\| 0.01 \\|\n\n\\| 52–58 岁 \\| 0.60 \\|\n\n\\| 58–66 岁 \\| 1.01 \\|\n\n\\| ≥ 66 岁 \\| 1.69 \\|"},"#text":{"text":"如果：患者得分 ≤ 其年龄对应的阈值\n\n\n\n- 解读： ***预后无显著差异。***该患者的长期预后在统计上与匹配的健康人群相似。\n- 建议措施： 继续UDCA治疗并常规监测。\n\n\n\n如果：患者得分 > 其年龄对应的阈值\n\n\n\n- 解读： ***预后显著更差。***该患者的长期预后在统计上差于匹配的健康人群。\n- 建议措施： 该患者对UDCA应答不佳，存在疾病进展的高风险。应强烈考虑启动二线治疗或转诊至专科中心。"}}}}